Skip to main content
CONNEQT HEALTH LIMITED logo

CONNEQT HEALTH LIMITED — Investor Relations & Filings

Ticker · CQT ISIN · AU0000420739 ASX Manufacturing
Open in API
Filings indexed 984 across all filing types
Latest filing 2026-04-30 Interim / Quarterly Rep…
Country AU Australia
Listing ASX CQT

About CONNEQT HEALTH LIMITED

https://conneqthealth.com

Conneqt Health Limited is a digital health technology company focused on the development of advanced vascular health monitoring solutions. The company specializes in integrating clinical-grade arterial health biomarkers into consumer-facing wearable and home-use devices. Utilizing patented SphygmoCor technology, its product suite includes the Conneqt Band, a wearable designed for monitoring central blood pressure and arterial stiffness, and the Conneqt Pulse, a multi-parameter health monitor. These devices are designed to provide comprehensive cardiovascular insights beyond traditional peripheral blood pressure measurements. The company's platform combines hardware with cloud-based analytics to support remote patient monitoring and personalized heart health management for consumers and healthcare professionals.

Recent filings

Filing Released Lang Actions
CONNEQT Investor Webinar Presentation 31 pages 4.4MB
Interim / Quarterly Report Classification · 90% confidence The document is a detailed corporate update from CONNEQT Health dated May 2026. It includes extensive information on company strategy, product lines, revenue growth, market positioning, operational changes, and marketing metrics. It contains quarterly revenue figures and discusses business trends and outlook. There is no indication that this is a full annual report or an official regulatory filing like a 10-K or interim report. It is not a transcript, audit report, or legal proceeding. The document is comprehensive and contains substantive financial and operational data for a quarter, indicating it is a quarterly or interim report rather than a brief announcement or presentation. Therefore, the best fit is an Interim / Quarterly Report (IR). Q3 2026
2026-04-30 English
Notification regarding unquoted securities - CQT 7 pages 22.6KB
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities' and details the issuance of unquoted convertible notes by CONNEQT HEALTH LIMITED. It includes specifics such as the number of securities issued, issue date, security description, and references to previous announcements (Appendix 3B). The content focuses on the issuance of new securities and related details, which aligns with announcements about capital changes or financing activities. There is no indication that this is a full financial report, earnings release, or management discussion. The document is not a report publication announcement or a certification. Therefore, the most appropriate classification is 'Share Issue/Capital Change' (SHA). The document length (7546 characters) supports it being a full announcement rather than a brief notice.
2026-04-29 English
Cleansing Statement 2 pages 125.2KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 29 April 2026 regarding the issuance of fully paid ordinary shares and convertible notes without disclosure under Part 6D.2 of the Corporations Act 2001 (Cth). It includes a cleansing statement under Section 708A(5)(e) of the Corporations Act, confirming compliance with disclosure obligations and the absence of excluded information. The document is short (2583 characters) and serves as a formal notice about a capital raising event without detailed financial data or analysis. It does not contain financial statements or substantive financial information, nor is it a report or presentation. This fits the definition of a Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes.
2026-04-29 English
Appendix 3Y x3 14 pages 219.2KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y' and repeatedly references 'Change of Director's Interest Notice' under ASX listing rule 3.19A.2. It details changes in securities holdings by company directors, including acquisitions and disposals of shares, options, and convertible notes. The document includes specific information about directors' direct and indirect interests, dates of changes, and nature of transactions. This matches the definition of a Director's Dealing report, which involves reporting personal share transactions by company directors and executives (insider trades). The document is not an announcement of a report, nor does it contain financial statements or management commentary, so it is not an Annual Report, Interim Report, or similar. It is also not a regulatory filing or certification letter. Therefore, the correct classification is Director's Dealing (DIRS). The document length and detail support a high confidence level.
2026-04-29 English
Application for quotation of securities - CQT 6 pages 18.3KB
Capital/Financing Update Classification · 95% confidence The document is an Appendix 2A form, which is an application for quotation of securities on the ASX. It details the number and type of securities to be quoted, issue date, issue price, and issued capital following quotation. It references a previous Appendix 3B announcement related to the securities issuance. The document is a formal announcement related to capital markets activity, specifically the quotation of securities following a prior issuance. This fits the category of a Capital/Financing Update (CAP) as it relates to the company's capital structure and securities issuance. The document is not a full financial report, earnings release, or regulatory filing unrelated to capital changes. Therefore, the appropriate classification is CAP with high confidence.
2026-04-28 English
Application for quotation of securities - CQT 6 pages 18.9KB
Capital/Financing Update Classification · 95% confidence The document is an Appendix 2A form, which is an application for quotation of securities on the ASX. It details the number and type of securities to be quoted, issue dates, and related information about securities issued as part of a previously announced transaction (Appendix 3B). The document is a formal announcement related to capital market activities, specifically the quotation of securities following an issuance. It is not a financial report, earnings release, or management discussion. It is also not a report publication announcement or certification. The content aligns with announcements about capital structure changes and securities issuance. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2026-04-28 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.